Changing concepts in the management of epithelial ovarian and cervical cancers

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Medical Journal of Australia

• Publication date

  1988-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5694/j.1326-5377.1988.tb133738.xPMID 3367841
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Initial therapy for early ovarian carcinoma

  1987cited by this paper
• Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.

  1987cited by this paper
• Whither carboplatin?--A replacement for or an alternative to cisplatin?

  1987cited by this paper
• Cancer statistics, 1987

  1987cited by this paper
• Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

  1987cited by this paper
• Intraperitoneal chromic phosphorous (P-32) as salvage therapy for persistent ovarian carcinoma

  1987cited by this paper
• High-dose carboplatin in refractory ovarian cancer patients.

  1987cited by this paper
• Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.

  1986cited by this paper
• Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity

  1986cited by this paper
• Intraperitoneal chemotherapy: a review.

  1986cited by this paper
• Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience.

  1986cited by this paper
• Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings.

  1986cited by this paper
• Second‐look laparotomy in managing epithelial ovarian carcinoma

  1986cited by this paper
• Complete remission at laparotomy: Still a gold standard in ovarian cancer?

  1986cited by this paper
• A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

  1986cited by this paper
• WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial.

  1986cited by this paper
• The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma.

  1986cited by this paper
• Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity.

  1986cited by this paper
• Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.

  1986cited by this paper
• A critical reassessment of second‐look laparotomy in epithelial ovarian carcinoma

  1986cited by this paper
• The significance of paraaortic node status in carcinoma of the cervix and endometrium.

  1986cited by this paper
• Role of Ca 125 as tumor marker in ovarian carcinoma

  1986cited by this paper
• Phase I/II trials of WR-2721 and cis-platinum.

  1986cited by this paper
• Cancer of uterine cervix stage IB: Treatment results and prognostic factors

  1986cited by this paper
• CA 125 surveillance and second-look laparotomy in ovarian carcinoma.

  1986cited by this paper
• CA 125 serum levels correlated with second-look operations among ovarian cancer patients.

  1986cited by this paper
• Carcinoma of the cervix, stage III. Results of radiation therapy

  1986cited by this paper
• The potential for optimal (less than or equal to 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: a prospective study.

  1986cited by this paper
• The potential for optimal (⩽ 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective study

  1986cited by this paper
• Ovarian trials at the Royal Marsden.

  1985cited by this paper
• Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel‐shaped cervical cancer

  1985cited by this paper
• Abdominopelvic Computed Tomography: Evaluation in Patients Undergoing Second‐Look Laparotomy for Ovarian Carcinoma

  1985cited by this paper
• Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

  1985cited by this paper
• Second-look laparotomy for ovarian carcinoma.

  1985cited by this paper
• Microscopic disease at second‐look laparotomy in advanced ovarian cancer

  1985cited by this paper
• Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea.

  1985cited by this paper
• Surgical management of advanced and recurrent cervical carcinoma: the place of pelvic exenteration.

  1985cited by this paper
• Treatment of cervical intraepithelial neoplasia III by hysterectomy without intervening conization in patients with adequate colposcopy

  1985cited by this paper
• Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.

  1985cited by this paper
• Clinical evaluation of high-dose cytarabine and cisplatin in recurrent cervical carcinoma.

  1985cited by this paper
• Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging

  1985cited by this paper
• Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.

  1985cited by this paper
• Surgical considerations in ovarian cancer.

  1985cited by this paper
• Experimental and clinical results with intraperitoneal cisplatin.

  1985cited by this paper
• Assessment of bleomycin, adriamycin and mitomycin‐C in the treatment of recurrent cervical cancer

  1985cited by this paper
• Preclinical studies identifying carboplatin as a viable cisplatin alternative.

  1985cited by this paper
• Abdominopelvic radiotherapy in ovarian cancer. A 10‐year experience

  1985cited by this paper
• High-dose cisplatin therapy in ovarian cancer.

  1985cited by this paper
• Palliative exenteration--what, when, and why?

  1985cited by this paper
• Prognosis of surgically determined complete responders in advanced ovarian cancer

  1985cited by this paper
• Human papillomavirus type 16 and early cervical neoplasia.

  1984cited by this paper
• A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.

  1984cited by this paper
• High-dose cisplatin in hypertonic saline.

  1984cited by this paper
• Pelvic exenteration: a 15-year experience in a general metropolitan hospital.

  1984cited by this paper
• Chemotherapy of advanced squamous carcinoma of the cervix: A phase I‐II study of high‐dose cisplatin and cyclophosphamide A pilot study of the Gynecologic Oncology Group

  1984cited by this paper
• Chemotherapy of ovarian cancer.

  1984cited by this paper
• The use of intraperitoneal chemotherapy in the treatment of ovarian cancer.

  1984cited by this paper
• A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

  1983cited by this paper
• Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study.

  1983cited by this paper
• Staging laparotomy in early ovarian cancer.

  1983cited by this paper
• Primary Cytoreductive Surgery for Epithelial Ovarian Cancer

  1983cited by this paper
• Current concepts in cancer: ovary--treatment for stages III and IV. Chemotherapy in advanced disease.

  1982cited by this paper
• Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.

  1982cited by this paper
• Second-look laparotomy in the management of gynecologic malignancy.

  1982cited by this paper
• Advanced Ovarian Cancer: Brief Intensive Combination Chemotherapy and Second-Look Operation

  1981cited by this paper
• The role of adjuvant therapy in Stage I ovarian cancer.

  1980cited by this paper
• The Princess Margaret Hospital study of ovarian cancer: stages I, II, and asymptomatic III presentations.

  1979cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis.

  1979cited by this paper
• Rewiew of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute.

  1979cited by this paper
• Intensive surgical and chemotherapeutic management of advanced ovarian cancer.

  1978cited by this paper
• Limited epithelial carcinoma of the ovary treated with curative intent by the intraperitoneal installation of radiocolloids

  1978cited by this paper
• Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.

  1978cited by this paper
• Chemotherapy of ovarian cancer.

  1978cited by this paper
• Is staging laparotomy in cervical cancer justifiable?

  1977cited by this paper
• Individualized treatment of ovarian cancer.

  1977cited by this paper
• Treatment of epithelial carcinoma of the ovary: operation, irradiation, and chemotherapy.

  1977cited by this paper
• External radiotherapy of ovarian cancer: standard approaches and new frontiers.

  1975cited by this paper
• Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

  1975cited by this paper
• Results of postoperative megavoltage radiotherapy of malignant surface epithelial tumors of the ovary.

  1975cited by this paper
• Incidence and histopathology of malignancies of the female genital organs in the United States.

  1974cited by this paper
• Treatment of ovarian carcinoma: possibilities for progress.

  1972cited by this paper
• Cancer of the ovary: Survival studies based upon operative therapy, chemotherapy, and radiotherapy

  1970cited by this paper
• Bone marrow depression in the pelvis after megavoltage irradiation for ovarian cancer

  1969cited by this paper
• Primary cancer of the ovary An analysis of 349 cases.

  1960cited by this paper

• The treatment of gynaecological malignancy in a general public hospital

  1992cites this paper
• Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.

  1992cites this paper
• Goals and rationale of cancer treatment

  1991cites this paper
• Medical oncology in the 1990s.

  1991cites this paper
• Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: A study of the Grupo de Estudio y Tratamiento Latino‐Americano del cancer

  1991cites this paper
• Ovarian carcinomas with transitional cell carcinoma pattern.

  1990cites this paper
• Staging in ovarian cancer

  1988cites this paper
• High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer.

  1988cites this paper